{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T03:07:39Z","timestamp":1788232059669,"version":"build-2803163510"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    <jats:bold>Introduction:<\/jats:bold>\n                    Peripheral artery disease (PAD) is an increasingly common disease, causing significant complications for patients. Trimetazidine (TMZ) not only improves clinical symptoms in PAD patients but also facilitates angiogenesis in ischemic hind limbs. Our aim was to find the function of TMZ in promoting angiogenesis and tissue perfusion in ischemic rat skeletal muscle.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    The rats underwent femoral artery ligation (FAL) and then treated with TMZ and saline. Hematoxylin-eosin and Masson\u2019s trichrome stain in the ischemic gastrocnemius muscle to analyze muscle morphology and atrophy. To identify angiogenesis and the tissue perfusion, CD31 immunohistochemical staining and laser speckle contrast imaging was conducted. Additionally, hind limb motor ability was measured. Finally, qRT-PCR and Western blotting were used to statistically analyze the expression levels of HIF-1\u03b1 and VEGF.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    Our study demonstrated significant enhancement in angiogenesis and tissue perfusion after FAL when treated with TMZ compared to the saline group. Histologically, it mitigates ischemia-induced muscle atrophy and inflammation, as well as reduces fibrosis progression in the TMZ group. Additionally, hind limb motor ability improved in rats treated with TMZ during motor experiments.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Discussion:<\/jats:bold>\n                    It suggests that TMZ can promote angiogenesis and improve tissue perfusion in ischemic skeletal muscle of rats by activating the HIF-1\u03b1\/VEGF signaling pathway. Additionally, it leads to significant improvement in ischemia-induced motor limitations in the hind limbs of rats.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2024.1436072","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T01:23:41Z","timestamp":1721697821000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Trimetazidine improves angiogenesis and tissue perfusion in ischemic rat skeletal muscle"],"prefix":"10.3389","volume":"15","author":[{"given":"Yongting","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenkai","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bailiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e23011","DOI":"10.1002\/jbt.23011","article-title":"Beneficial effect of trimetazidine on folic acid-induced acute kidney injury in mice: role of HIF-1\u03b1\/HO-1","volume":"36","author":"Abdelrahman","year":"2022","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1096\/fj.04-2304fje","article-title":"Physiological activation of hypoxia inducible factor-1 in human skeletal muscle","volume":"19","author":"Ameln","year":"2005","journal-title":"Faseb J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in signaling and disease: beyond discovery and development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell."},{"key":"B4","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1093\/emboj\/cdg392","article-title":"HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia","volume":"22","author":"Berra","year":"2003","journal-title":"Embo J."},{"key":"B5","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.jvs.2007.10.036","article-title":"Trimetazidine reduces early and long-term effects of experimental renal warm ischemia: a dose effect study","volume":"47","author":"Cau","year":"2008","journal-title":"J. Vasc. Surg."},{"key":"B6","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1177\/1358863x20909992","article-title":"Neovascularization in carotid atherosclerotic plaques can be effectively evaluated by superb microvascular imaging (SMI): initial experience","volume":"25","author":"Chen","year":"2020","journal-title":"Vasc. Med."},{"key":"B7","first-page":"188","article-title":"Trimetazidine hydrochloride as a new treatment for patients with peripheral vascular disease-an exploratory trial","volume":"20","author":"Chu","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"Cd010680","DOI":"10.1002\/14651858.CD010680.pub2","article-title":"Ankle brachial index for the diagnosis of lower limb peripheral arterial disease","volume":"9","author":"Crawford","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1161\/cir.0000000000001005","article-title":"Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American heart association","volume":"144","author":"Criqui","year":"2021","journal-title":"Circulation"},{"key":"B10","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/jcsm.12097","article-title":"Improvement of skeletal muscle performance in ageing by the metabolic modulator trimetazidine","volume":"7","author":"Ferraro","year":"2016","journal-title":"J. Cachexia Sarcopenia Mus."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1136\/hrt.2011.226332","article-title":"Effect of partial inhibition of fatty acid oxidation by trimetazidine on whole body energy metabolism in patients with chronic heart failure","volume":"97","author":"Fragasso","year":"2011","journal-title":"Heart"},{"key":"B12","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/nnano.2017.134","article-title":"Topical tissue nano-transfection mediates non-viral stroma reprogramming and rescue","volume":"12","author":"Gallego-Perez","year":"2017","journal-title":"Nat. Nanotechnol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/s41569-021-00663-9","article-title":"Update on the pathophysiology and medical treatment of peripheral artery disease","volume":"19","author":"Golledge","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.freeradbiomed.2020.11.019","article-title":"Nrf2 knockout altered brain iron deposition and mitigated age-related motor dysfunction in aging mice","volume":"162","author":"Han","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1161\/01.res.86.5.580","article-title":"The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase","volume":"86","author":"Kantor","year":"2000","journal-title":"Circ. Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1161\/01.Res.0000102937.50486.1b","article-title":"Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1","volume":"93","author":"Kelly","year":"2003","journal-title":"Circ. Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1161\/circresaha.116.303518","article-title":"The genetic basis of peripheral arterial disease: current knowledge, challenges, and future directions","volume":"116","author":"Kullo","year":"2015","journal-title":"Circ. Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.mvr.2010.09.008","article-title":"Mutant hypoxia inducible factor-1\u03b1 improves angiogenesis and tissue perfusion in ischemic rabbit skeletal muscle","volume":"81","author":"Li","year":"2011","journal-title":"Microvasc. Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1038\/nprot.2009.185","article-title":"Evaluation of postnatal arteriogenesis and angiogenesis in a mouse model of hind-limb ischemia","volume":"4","author":"Limbourg","year":"2009","journal-title":"Nat. Protoc."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.3109\/0886022x.2014.949765","article-title":"Effects of trimetazidine on the Akt\/eNOS signaling pathway and oxidative stress in an in vivo rat model of renal ischemia-reperfusion","volume":"36","author":"Mahfoudh-Boussaid","year":"2014","journal-title":"Ren. Fail."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1161\/atvbaha.120.313831","article-title":"Skeletal muscle pathology in peripheral artery disease: a brief review","volume":"40","author":"McDermott","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European society of cardiology","volume":"34","author":"Montalescot","year":"2013","journal-title":"Eur. Heart J."},{"key":"B23","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1111\/eci.12333","article-title":"HIF-1\u03b1 and HIF-2\u03b1 induce angiogenesis and improve muscle energy recovery","volume":"44","author":"Niemi","year":"2014","journal-title":"Eur. J. Clin. Invest."},{"key":"B24","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.ejvs.2006.09.024","article-title":"Inter-society consensus for the management of peripheral arterial disease (TASC II)","volume":"33","author":"Norgren","year":"2007","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e1255","DOI":"10.1111\/aos.14845","article-title":"MicroRNAs and the HIF\/VEGF axis in ocular neovascular diseases","volume":"99","author":"Plastino","year":"2021","journal-title":"Acta Ophthalmol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1001\/jama.2021.2126","article-title":"Lower extremity peripheral artery disease without chronic limb-threatening ischemia: a review","volume":"325","author":"Polonsky","year":"2021","journal-title":"Jama"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1172\/jci118237","article-title":"Myoglobin O2 desaturation during exercise. Evidence of limited O2 transport","volume":"96","author":"Richardson","year":"1995","journal-title":"J. Clin. Invest."},{"key":"B28","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-inducible factors in physiology and medicine","volume":"148","author":"Semenza","year":"2012","journal-title":"Cell."},{"key":"B29","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.phrs.2004.06.006","article-title":"Effect of trimetazidine on renal ischemia\/reperfusion injury in rats","volume":"50","author":"Singh","year":"2004","journal-title":"Pharmacol. Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e1020","DOI":"10.1016\/s2214-109x(19)30255-4","article-title":"Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis","volume":"7","author":"Song","year":"2019","journal-title":"Lancet Glob. Health"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1161\/circulationaha.108.778019","article-title":"Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy","volume":"118","author":"Tuunanen","year":"2008","journal-title":"Circulation"},{"key":"B32","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.phrs.2011.01.003","article-title":"Trimetazidine improves exercise performance in patients with peripheral arterial disease","volume":"63","author":"Vitale","year":"2011","journal-title":"Pharmacol. Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41420-021-00648-0","article-title":"Trimetazidine attenuates dexamethasone-induced muscle atrophy via inhibiting NLRP3\/GSDMD pathway-mediated pyroptosis","volume":"7","author":"Wang","year":"2021","journal-title":"Cell. Death Discov."},{"key":"B34","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1124\/jpet.109.150839","article-title":"Pharmacological preconditioning of mesenchymal stem cells with trimetazidine (1-[2,3,4-trimethoxybenzyl]piperazine) protects hypoxic cells against oxidative stress and enhances recovery of myocardial function in infarcted heart through Bcl-2 expression","volume":"329","author":"Wisel","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1080\/07853890.2021.1925147","article-title":"Trimetazidine ameliorates hindlimb ischaemic damage in type 2 diabetic mice","volume":"53","author":"Yang","year":"2021","journal-title":"Ann. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.3892\/etm.2019.7705","article-title":"Trimetazidine inhibits cardiac fibrosis by reducing reactive oxygen species and downregulating connective tissue growth factor in streptozotocin-induced diabetic rats","volume":"18","author":"Zhao","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e0174703","DOI":"10.1371\/journal.pone.0174703","article-title":"Methodological concerns with laser speckle contrast imaging in clinical evaluation of microcirculation","volume":"12","author":"Z\u00f6tterman","year":"2017","journal-title":"PLoS One"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1436072\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T01:23:43Z","timestamp":1721697823000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1436072\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,23]]},"references-count":37,"alternative-id":["10.3389\/fphar.2024.1436072"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1436072","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,23]]},"article-number":"1436072"}}